ACT executive director Morgan Reed issued the following statement today in response to the FDA’s draft guidance that would exempt many low risk medical apps and devices from FDA review: Today's draft guidance continues the FDA's strong push towards innovation-friendly policies. This clarification will help provide a clearer path for [...]